Last updated: February 19, 2026
Who Are the Major Suppliers?
Major pharmaceutical companies and contract manufacturing organizations (CMOs) supply metoclopramide hydrochloride globally. These suppliers have the capacity to produce pharmaceutical-grade active pharmaceutical ingredients (APIs) aligning with regulatory standards such as those from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional agencies.
Leading Pharmaceutical Manufacturers
| Company Name |
Headquarters |
API Production Capacity |
Market Regions |
Certification/Standards |
| Zhejiang Hisun Pharmaceutical |
China |
Over 500 tons/year |
Asia, Europe, North America |
GMP, ISO 9001, ISO 14001 |
| Jiangsu Hengrui Medicine |
China |
Approximately 300 tons/year |
Asia, Europe |
GMP, ISO 9001 |
| Synthesis GmbH |
Germany |
Estimated 50-100 tons/year |
Europe, NorthAmerica |
GMP, Eudralex conforming standards |
| VHB Life Sciences Ltd |
India |
100+ tons/year |
India, parts of Asia and Europe |
GMP, ISO 9001 |
Contract Manufacturing Organizations (CMOs)
| CMO Name |
Location |
Services Provided |
Notable Clients |
| Puracap Pharma |
India |
API manufacturing, custom synthesis |
Multiple generic drug companies |
| Amoli Organics |
India |
API synthesis, process R&D |
Several global pharma companies |
| Fareva |
France, India |
API manufacturing, formulation |
Global pharma brands |
| Hikal Ltd. |
India |
API manufacturing, research services |
International clients |
Geographic Distribution and Regulatory Considerations
- Chinese and Indian companies dominate API manufacturing due to lower costs, high capacity, and existing export infrastructure.
- European and North American suppliers tend to emphasize compliance with stricter regulatory standards, including Good Manufacturing Practice (GMP) certifications.
- Certain suppliers maintain multiple certifications, including ISO 9001, ISO 14001, and GDP compliance, necessary for international distribution.
Regulatory and Certification Landscape
- API suppliers must demonstrate compliance with regional Good Manufacturing Practice (GMP) standards.
- Many suppliers hold certifications from authoritative bodies such as the U.S. FDA and EMA.
- Importing companies often verify certification status before procurement.
Supply Chain Risks
- Dependence on Chinese and Indian manufacturers increases vulnerability to supply disruptions due to geopolitical, regulatory, or manufacturing issues.
- Recent supply chain investigations have highlighted quality control concerns in some regions, prompting buyers to favor suppliers with recognized certifications.
Market Trends
- Growing demand for generics, especially in emerging markets, increases overall API demand.
- Companies are investing in process improvements to meet evolving quality standards.
- Potential for market entry by new API producers could influence pricing and supply stability.
Summary of Key Suppliers
- Zhejiang Hisun Pharmaceutical remains the dominant Chinese API producer.
- European players like Synthesis GmbH focus on high-quality standards.
- Indian companies such as Hikal Ltd. and Amoli Organics offer cost-effective options with GMP compliance.
- Contract manufacturers provide flexible, scalable solutions to meet varying demands.
Key Takeaways
- The primary suppliers for metoclopramide hydrochloride are based in China, India, and Europe.
- Quality and regulatory compliance are critical for selecting suppliers, with many holding GMP and international certifications.
- The supply landscape is affected by geopolitical risks, and buyers prefer suppliers with demonstrated track records of compliance.
- Market growth driven by generics propels demand, but supply chain stability remains a concern.
- Contract manufacturing organizations provide alternative sourcing options, especially for scalable or specialized production.
FAQs
1. What regions are the main suppliers of metoclopramide hydrochloride?
China, India, and Europe are the primary regions, with Chinese and Indian producers dominating due to cost advantages.
2. How do certifications influence supplier selection?
Certifications such as GMP, ISO 9001, and EMA compliance ensure quality standards meet regulatory requirements, reducing risk of non-compliance.
3. Are there any regional restrictions on importing metoclopramide hydrochloride?
Regulatory restrictions depend on regional drug approval processes. Buyers must verify that suppliers' API complies with local regulations before importation.
4. Can contract manufacturing organizations supply custom formulations of metoclopramide hydrochloride?
Yes, CMOs can provide custom synthesis and formulation services, offering scalable options for manufacturers.
5. What are the risks associated with supply chain reliance on Chinese and Indian suppliers?
Risks include geopolitical tensions, regulatory changes, and quality control concerns, which may disrupt supply continuity.
References
[1] U.S. Food and Drug Administration. (2022). API Certification Guidelines. Retrieved from https://www.fda.gov/regulatory-compliance/gmp-compliance/api-certification-guidelines
[2] European Medicines Agency. (2022). Quality standards for APIs. Retrieved from https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice
[3] MarketResearch.com. (2022). Global API Market Report. Available at: https://www.marketresearch.com
[4] PharmTech.com. (2021). Trends in API Supply Chain Management. Retrieved from https://www.pharmtech.com/view/trends-in-api-supply-chain-management
